Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Robert L Rothbard"'
Autor:
Jeffrey L. Anderson, Robert L. Rothbard, Sherman G. Sorensen, Patricia G. Fitzpatrick, R. A. Hakworthy, Victor J. Marder
Publikováno v:
Clinical cardiology.
Adverse events data of a randomized, multicenter, angiographically controlled trial of intracoronary streptokinase and intravenous anistreplase, or anisoylated plasminogen streptokinase activator complex (APSAC) are presented. The frequency of severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a229f6e29b73372e1578944137e2ba7
https://pubmed.ncbi.nlm.nih.gov/2182234
https://pubmed.ncbi.nlm.nih.gov/2182234
Autor:
W B Hood, D M Caton, Charles W. Francis, Robert L. Rothbard, Victor J. Marder, Patricia G. Fitzpatrick
Publikováno v:
Circulation. 71:562-570
The influence of a systemic lytic state on reperfusion obtained after intracoronary streptokinase (SK) therapy has been evaluated in 15 patients with acute myocardial infarction and complete coronary occlusion. Coronary angiographic studies and measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af46c04b8e7a59a131433ab7f1500fb6
https://doi.org/10.1161/01.cir.71.3.562
https://doi.org/10.1161/01.cir.71.3.562
Publikováno v:
Clinical Pharmacology and Therapeutics. 38:84-88
The hemodynamic and respiratory effects of dezocine and ciramadol, two agonist-antagonist analgesics, were compared with those of morphine in 30 patients undergoing diagnostic cardiac catheterization. Each subject received a single intravenous dose o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a31fb221e92ec0af763482bba89f7e7
https://doi.org/10.1038/clpt.1985.139
https://doi.org/10.1038/clpt.1985.139
Autor:
Ronald L. Menlove, Charles F. Dahl, Gary P. Symkoviak, Jeffrey L. Anderson, Robert L. Rothbard, Sherman G. Sorensen, Arthur D. Hagan, Harry W. Eckerson, Patricia G. Fitzpatrick, Rosemary A. Hackworthy, Kevin F. Browne, Victor J. Marder, William H. Barry
Publikováno v:
Journal of the American College of Cardiology. (6):1153-1163
The recent establishment of a firm therapeutic role for reperfusion in acute myocardial infarction has stimulated interest in the development of more ideal thrombolylic agents. Anisoylated plasminogen streptokinase activator complex (APSAC) is a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b37cdfe162f08bbdc9119326917c081
Autor:
Robert L. Rothbard
Publikováno v:
Drugs. 33:276-278
The safety and tolerance data of the preliminary results of a randomised, parallel group, multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in patients with myocardial inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4581aa79fdbc156409d2a82e27fc139
https://doi.org/10.2165/00003495-198700333-00051
https://doi.org/10.2165/00003495-198700333-00051
Autor:
Robert L. Rothbard, Jeffrey L. Anderson, Ronald L. Menlove, Rosemary A. Hackworthy, Patricia G. Fitzpatrick, Sherman G. Sorensen, William H. Barry
Publikováno v:
American heart journal. 116(4)
The effect of early coronary artery reperfusion on ECG and enzymatic parameters was examined in 240 patients with acute myocardial infarction. These patients had participated in a randomized trial comparing intravenous anisoylated plasminogen strepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9e7bc55549a79ae60b33959bd082ee
https://pubmed.ncbi.nlm.nih.gov/3051985
https://pubmed.ncbi.nlm.nih.gov/3051985
Autor:
Charles W. Francis, Robert L. Rothbard, Victor J. Marder, Elliot C. Norry, Patricia G. Fitzpatrick
Publikováno v:
Drugs. 33
Anisoylated plasminogen streptokinase activator complex (APSAC) is well tolerated when given as an intravenous bolus dose over 2 to 4 minutes. The intravenous administration of 30U was rapidly effective in patients with coronary artery occlusion, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71577c1d972f30a83b615281c312cce
https://pubmed.ncbi.nlm.nih.gov/3315577
https://pubmed.ncbi.nlm.nih.gov/3315577
Autor:
Robert L. Rothbard, Sherman G. Sorensen, V Harder, Patricia G. Fitzpatrick, Rosemary A. Hackworthy, Jeffrey L. Anderson
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
To compare the reperfusion potential of intravenous anisoy-lated plasminogen streptokinase activator complex (APSAC) a new thrombolytic, and standard therapy with intracoronary streptokinase in acute myocardial infarction (AMI), a randomized multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::964efbf9b6b37aa915e70c48b1517ba0
https://doi.org/10.1055/s-0038-1643621
https://doi.org/10.1055/s-0038-1643621
Autor:
Benjamin Brenner, Christopher Cox, Sherman G. Sorensen, Jeffrey L. Anderson, Patricia G. Fitzpatrick, Victor J. Marder, Robert L. Rothbard, Rosemary A. Hackworthy, Charles W. Francis
Publikováno v:
The American journal of cardiology. 63(17)
This study was designed to investigate the possible role of pre- and posttreatment plasma D-dimer concentration as a reflection of coronary artery thrombolysis. Blood was collected from 206 patients with angiographically documented acute coronary occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc4c7e994f5191f05d615d07c7e1f9c
https://pubmed.ncbi.nlm.nih.gov/2653016
https://pubmed.ncbi.nlm.nih.gov/2653016
Rapid Lysis of Coronary Artery Thrombi with Anisoylated Plasminogen: Streptokinase Activator Complex
Publikováno v:
Annals of Internal Medicine. 104:304
The ability of anisoylated plasminogen: streptokinase activator complex (APSAC) to induce coronary artery reperfusion after bolus intravenous injection (2 to 4 minutes) was assessed in 29 patients with acute transmural myocardial infarction and compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5245fd15ec4699a8efc43841ea1e4c7
https://doi.org/10.7326/0003-4819-104-3-304
https://doi.org/10.7326/0003-4819-104-3-304